首页|复方谷氨酰胺肠溶胶囊联合双歧杆菌三联活菌胶囊治疗腹泻型肠易激综合征的疗效分析

复方谷氨酰胺肠溶胶囊联合双歧杆菌三联活菌胶囊治疗腹泻型肠易激综合征的疗效分析

扫码查看
目的 探讨双歧杆菌三联活菌胶囊联合复方谷氨酰胺肠溶胶囊治疗腹泻型肠易激综合征的效果.方法 选取兰州石化总医院 2021 年7 月—2023 年7 月收治的 60 例腹泻型肠易激综合征患者为研究对象,采用随机数字表法将其分为对照组和观察组,每组 30 例.对照组采用复方谷氨酰胺肠溶胶囊治疗,观察组在对照组基础上联合双歧杆菌三联活菌胶囊治疗,持续用药 4 周.比较两组临床疗效、症状改善情况、症状严重程度、肠黏膜屏障功能及不良反应发生情况.结果 观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05).观察组止泻时间短于对照组,每日腹泻次数及急性应激次数均少于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组肠易激综合征症状严重程度量表评分低于对照组,差异有统计学意义(P<0.05).治疗后,观察组血清内毒素、二胺氧化酶、D-乳酸水平均低于对照组,组间差异有统计学意义(P<0.05).治疗期间两组均未发生不良反应.结论 复方谷氨酰胺肠溶胶囊联合双歧杆菌三联活菌胶囊治疗腹泻型肠易激综合征,能有效缓解患者疾病症状,修复肠黏膜屏障,且安全性良好.
Therapeutic Effect of Compound Glutamine Enteric Coated Capsules Combined with Bifidobacterium Triple Viable Capsules in the Treatment of Diarrhea Type Irritable Bowel Syndrome and Its Impact on Intestinal Mucosal Barrier Function
Objective To explore the effect of bifidobacterium triple viable capsules combined with compound glutamine enteric coated capsules in the treatment of diarrhea type irritable bowel syndrome.Methods Sixty patients with diarrhea type irritable bowel syndrome admitted to Lanzhou Petrochemical General Hospital from July 2021 to July 2023 were selected as the research subjects.They were randomly divided into a control group and an observation group using a random number table method,with 30 cases in each group.The control group was treated with compound glutamine enteric coated capsules alone,while the observation group was treated with bifidobacterium triple viable capsules in combination on the basis of the control group for 4 weeks.The clinical efficacy,symptom improvement,symptom severity,intestinal mucosal barrier function and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).The observation group had a shorter time to stop diarrhea compared to the control group,with fewer daily episodes of diarrhea and acute stress compared to the control group,and the differences between the groups were statistically significant(P<0.05).After treatment,the severity scale score of symptoms of irritable bowel syndrome in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of serum endotoxin,diamine oxidase,and D-lactate in the observation group were lower than those in the control group,and the differences between the groups were statistically significant(P<0.05).During the treatment period,neither group experienced any adverse reactions.Conclusion Combined treatment with compound glutamine enteric coated capsules and bifidobacterium triple viable capsules in the treatment of diarrhea type irritable bowel syndrome can effectively relieve disease symptoms and repair intestinal mucosal barrier in patients,with good safety.

Diarrhea type irritable bowel syndromeBifidobacterium triple viable capsulesCompound glutamine enteric coated capsulesIntestinal mucosal barrier functionClinical efficacy

周鑫

展开 >

兰州石化总医院消化内科,甘肃兰州 730060

腹泻型肠易激综合征 双歧杆菌三联活菌胶囊 复方谷氨酰胺肠溶胶囊 肠黏膜屏障功能 临床疗效

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(7)